300558.SZ SHZ
Betta Pharmaceuticals Co., Ltd.
1W: -0.5%
1M: +0.0%
3M: -24.9%
YTD: +5.6%
1Y: -25.1%
3Y: +0.2%
5Y: -50.6%
¥50.48 ($7.53)
+1.52 (+3.10%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥21.4B ($3.2B)
52W Range40.1-78.18
Volume18,935,150
Avg Volume18,167,756
Beta0.43
Dividend¥0.15
Analyst Ratings
No analyst coverage
Company Info
CEOLieming Ding
Employees1,785
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2016-11-09
Websitebettapharma.com
No. 355, Xingzhong Road
Hangzhou, ZH 311100
CN
Hangzhou, ZH 311100
CN
86 571 8613 0357
About Betta Pharmaceuticals Co., Ltd.
Betta Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of oncology treatments. Among its key offerings are Icotinib hydrochloride, an orally taken epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and Ensartinib hydrochloride, an anaplastic lymphoma kinase (ALK) inhibitor, both utilized in the management of non-small-cell lung cancer. Founded in 2003, the firm is headquartered in Hangzhou, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found